|
|
||||||||
Ann Thorac Surg 1980;30:247-258
© 1980 The Society of Thoracic Surgeons
From the Departments of Surgery and Biostatistics, University of Alabama School of Medicine and Medical Center, Birmingham, AL
* Address reprint requests to Dr. Karp, Department of Surgery, University of Alabama Medical Center, University Station, Birmingham, AL 35294
From November, 1973, through June, 1978, 428 operations in 425 patients were performed for replacement of aortic, mitral, or aortic plus mitral valves, utilizing 277 Hancock and 180 Carpentier-Edwards bioprostheses. Actuarially determined survival at 36 months was similar for all three groups and compared favorably with our experience with the Björk-Shiley prosthesis. Certain patient-related variables influencing late survival were identified by multivariate analysis and included previous operation for congenital heart disease, coronary artery bypass grafting in nonaortic valve replacement, race (black), age at operation, and New York Heart Association Functional Class. A small but definite incidence of thromboembolism occurred in all three groups, again similar to our experience with the Björk-Shiley prosthesis. Multivariate analysis identified four factors influencing risk of thromboembolism: previous cardiac operation, age, double-valve replacement, and rhythm at discharge. Valve degeneration occurred, primarily in children and young adults. Over the medium term, the porcine bioprosthesis compared favorably with mechanical prostheses in terms of survival, function, and thromboembolism. Certain patient-related variables affecting survival may be modified by earlier surgical intervention.
This article has been cited by other articles:
![]() |
R. P. Whitlock, J. C. Sun, S. E. Fremes, F. D. Rubens, and K. H. Teoh Antithrombotic and Thrombolytic Therapy for Valvular Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest, February 1, 2012; 141(2_suppl): e576S - e600S. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Monagle, A. K. C. Chan, N. A. Goldenberg, R. N. Ichord, J. M. Journeycake, U. Nowak-Gottl, and S. K. Vesely Antithrombotic Therapy in Neonates and Children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest, February 1, 2012; 141(2_suppl): e737S - e801S. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Salem, P. T. O'Gara, C. Madias, and S. G. Pauker Valvular and Structural Heart Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 593S - 629S. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Monagle, E. Chalmers, A. Chan, G. deVeber, F. Kirkham, P. Massicotte, and A. D. Michelson Antithrombotic Therapy in Neonates and Children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 887S - 968S. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Salem, P. D. Stein, A. Al-Ahmad, H. I. Bussey, D. Horstkotte, N. Miller, and S. G. Pauker Antithrombotic Therapy in Valvular Heart Disease--Native and Prosthetic: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 457S - 482S. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Stein, J. S. Alpert, H. I. Bussey, J. E. Dalen, and A. G.G. Turpie Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves Chest, January 1, 2001; 119(2009): 220S - 227S. [Full Text] [PDF] |
||||
![]() |
L. H. Edmunds Jr. Thrombotic and Bleeding Complications of Prosthetic Heart Valves Ann. Thorac. Surg., October 1, 1987; 44(4): 430 - 445. [Abstract] [PDF] |
||||
![]() |
D. Johnson and L. Gonzalez-Lavin Myocardial Infarction Secondary to Calcific Embolization: An Unusual Complication of Bioprosthetic Valve Degeneration Ann. Thorac. Surg., July 1, 1986; 42(1): 102 - 103. [Abstract] [PDF] |
||||
![]() |
Cerebral Embolism Task Force Cardiogenic Brain Embolism Arch Neurol, January 1, 1986; 43(1): 71 - 84. [Abstract] [PDF] |
||||
![]() |
T. E. David, W. I. C. Ho, and G. T. Christakis Thromboembolism in Patients with Aortic Porcine Bioprostheses Ann. Thorac. Surg., September 1, 1985; 40(3): 229 - 233. [Abstract] [PDF] |
||||
![]() |
C. Zussa, G. Ottino, M. di Summa, G. A. Poletti, G. F. Zattera, S. Pansini, and M. Morea Porcine Cardiac Bioprostheses: Evaluation of Long-term Results in 990 Patients Ann. Thorac. Surg., March 1, 1985; 39(3): 243 - 250. [Abstract] [PDF] |
||||
![]() |
R. DeWall, L. C. Pelletier, A. Panebianco, G. Hicks, B. Schuster, R. Bonan, J.-P. Martineau, and L. Yip Five-Year Clinical Experience with the Omniscience Cardiac Valve Ann. Thorac. Surg., September 1, 1984; 38(3): 275 - 280. [Abstract] [PDF] |
||||
![]() |
A. Starr and G. L. Grunkemeier Selection of a Prosthetic Heart Valve JAMA, April 6, 1984; 251(13): 1739 - 1742. [Abstract] [PDF] |
||||
![]() |
L. Nunez, M. G. Aguado, J. L. Larrea, D. Celemin, and J. Oliver Prevention of Thromboembolism Using Aspirin after Mitral Valve Replacement with Porcine Bioprosthesis Ann. Thorac. Surg., January 1, 1984; 37(1): 84 - 87. [Abstract] [PDF] |
||||
![]() |
H. Bolooki, S. Mallon, G. A. Kaiser, R. J. Thurer, and J. Kieval Failure of Hancock Xenograft Valve: Importance of Valve Position (4- to 9-Year Follow-up) Ann. Thorac. Surg., September 1, 1983; 36(3): 246 - 252. [Abstract] [PDF] |
||||
![]() |
L. Gonzalez-Lavin, S. Chi, T. C. Blair, J. Y. Jung, A. G. Fabaz, P. M. McFadden, B. Lewis, and G. Daughters Five-Year Experience with the Ionescu-Shiley Bovine Pericardial Valve in the Aortic Position Ann. Thorac. Surg., September 1, 1983; 36(3): 270 - 280. [Abstract] [PDF] |
||||
![]() |
W. Daenen, A. Nevelsteen, P. van Cauwelaert, E. de Maesschalk, J. Willems, and G. Stalpaert Nine Years' Experience with the Bjork-Shiley Prosthetic Valve: Early and Late Results of 932 Valve Replacements Ann. Thorac. Surg., June 1, 1983; 35(6): 651 - 663. [Abstract] [PDF] |
||||
![]() |
M. I. Ionescu, D. R. Smith, S. S. Hasan, M. Chidambaram, and A. P. Tandon Clinical Durability of the Pericardial Xenograft Valve: Ten Years' Experience with Mitral Replacement Ann. Thorac. Surg., September 1, 1982; 34(3): 265 - 277. [Abstract] [PDF] |
||||
![]() |
L. Nunez, M. G. Aguado, D. Celemin, A. Iglesias, and J. L. Larrea Aspirin or Coumadin as the Drug of Choice for Valve Replacement with Porcine Bioprosthesis Ann. Thorac. Surg., April 1, 1982; 33(4): 354 - 358. [Abstract] [PDF] |
||||
![]() |
E. V. Bennett Jr., F. L. Grover, and J. K. Trinkle Porcine Valve Bioprosthesis: Early Thrombosis with Systemic Emboli Ann. Thorac. Surg., February 1, 1982; 33(2): 197 - 199. [Abstract] [PDF] |
||||
![]() |
A. M. Borkon, C. L. McIntosh, T. J. Von Rueden, and A. G. Morrow Mitral Valve Replacement with the Hancock Bioprosthesis: Five- to Ten-Year Follow-up Ann. Thorac. Surg., August 1, 1981; 32(2): 127 - 137. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |